<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Based on repeated interval analyses, radiotherapy and <z:chebi fb="0" ids="35610">cytostatic</z:chebi> drug therapy were stepwise intensified and combined in 264 patients diagnosed between 1976 and 1981 as having histopathologically low-malignant <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e>-centrocytic (cb/cc; n = 106), centrocytic (cc; n = 34) or immunocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 124) </plain></SENT>
<SENT sid="1" pm="."><plain>The number of treatment failures and recurrences were clearly reduced </plain></SENT>
<SENT sid="2" pm="."><plain>There were three prognostic steps in survival probability: 90% after seven years for stages IA-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IVA</z:e> of the cb/cc <z:hpo ids='HP_0002665'>lymphoma</z:hpo> as well as for the extranodal lymphoplasmocytoid and lymphoplasmocytic <z:e sem="disease" ids="C0242647,C0334633" disease_type="Neoplastic Process" abbrv="">immunocytomas</z:e>, stages I-IV of Ann Arbor, and stages 0-II of the Rai classifications </plain></SENT>
<SENT sid="3" pm="."><plain>In the Rai stages III and IV these <z:e sem="disease" ids="C0242647,C0334633" disease_type="Neoplastic Process" abbrv="">immunocytomas</z:e> had a definitely worse prognosis, at 60% </plain></SENT>
<SENT sid="4" pm="."><plain>Prognostically most unfavourable, at levels of around or below 30%, were the B forms of cb/cc <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, <z:hpo ids='HP_0000001'>all</z:hpo> stages of centrocytoma and the polymorph-cell <z:e sem="disease" ids="C0242647,C0334633" disease_type="Neoplastic Process" abbrv="">immunocytomas</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The survival rate of the cb/cc <z:hpo ids='HP_0002665'>lymphomas</z:hpo> was increased by about 33%, compared with cases of <z:e sem="disease" ids="C0024301" disease_type="Neoplastic Process" abbrv="">Brill-Symmers' disease</z:e> between 1970 and 1975 </plain></SENT>
<SENT sid="6" pm="."><plain>The alternating use of <z:chebi fb="0" ids="35610">cytostatic</z:chebi> combinations seems to be more favourable among the previously little affected centrocytomas and the polymorph-cell <z:e sem="disease" ids="C0242647,C0334633" disease_type="Neoplastic Process" abbrv="">immunocytomas</z:e> </plain></SENT>
</text></document>